Jade Biosciences, Inc. (JBIO)
16.57
+0.17
(+1.04%)
USD |
NASDAQ |
Nov 11, 16:00
16.57
0.00 (0.00%)
After-Hours: 17:43
Jade Biosciences Net Income (Quarterly) : -55.76M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -55.76M |
| March 31, 2026 | -40.37M |
| December 31, 2025 | -31.93M |
| September 30, 2025 | -25.18M |
| June 30, 2025 | -32.13M |
| March 31, 2025 | -38.17M |
| December 31, 2024 | -5.43M |
| September 30, 2024 | -16.28M |
| June 30, 2024 | -24.78M |
| March 31, 2024 | -23.19M |
| December 31, 2023 | -20.41M |
| September 30, 2023 | -19.56M |
| June 30, 2023 | -19.02M |
| Date | Value |
|---|---|
| March 31, 2023 | -16.52M |
| December 31, 2022 | -15.02M |
| September 30, 2022 | -13.59M |
| June 30, 2022 | -11.99M |
| March 31, 2022 | -10.91M |
| December 31, 2021 | -8.223M |
| September 30, 2021 | -6.184M |
| June 30, 2021 | -5.775M |
| March 31, 2021 | -2.781M |
| December 31, 2020 | -3.666M |
| September 30, 2020 | -2.307M |
| June 30, 2020 | -2.202M |
| March 31, 2020 | -1.436M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | -0.311M |
| Savara, Inc. | -42.99M |
| Vericel Corp. | 14.16M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 55.76M |
| EPS Diluted (Quarterly) | -0.7569 |
| Enterprise Value | 581.74M |
| Earnings Yield | -15.77% |
| Normalized Earnings Yield | -15.77 |